Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value

$6.43−0.10 (-1.53%)

Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%

Earnings

Embecta's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 24, 2026

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$271.70M

-8.1% on a year earlier

Adjusted earnings per diluted share, Q3 FY2026

$0.56

$1.12 a year earlier

Latest guidance

Raised

May 5, 2026 · 11 items

Quarterly results

Revenue and earnings per share from each of Embecta's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Sep 30, 2026	Nov 24, 2026Expected	–	–	–	–	–
Q3 FY2026ended Jun 30, 2026	Aug 7, 2026before the open	$271.70M	-8.1%	$0.36	$0.56	Release
Q2 FY2026ended Mar 31, 2026	May 5, 2026before the open	$221.80M	-14.4%	-$0.07	$0.27	Release
Q1 FY2026ended Dec 31, 2025	Feb 5, 2026before the open	$261.20M	-0.3%	$0.74	$0.71	Release
Q4 FY2025ended Sep 30, 2025	Nov 25, 2025before the open	$264.00M	-7.7%	$0.45	$0.50	Release
Q3 FY2025ended Jun 30, 2025	Aug 8, 2025before the open	$295.50M	+8.4%	$0.78	$1.12	Release
Q2 FY2025ended Mar 31, 2025	May 9, 2025before the open	$259.00M	-9.8%	$0.40	$0.70	Release
Q1 FY2025ended Dec 31, 2024	Feb 6, 2025before the open	$261.90M	-5.6%	$0.00	$0.65	Release
Q4 FY2024ended Sep 30, 2024	Nov 26, 2024before the open	$286.10M	+1.5%	$0.25	$0.45	Release
Q3 FY2024ended Jun 30, 2024	Aug 9, 2024before the open	$272.50M	-4.8%	$0.25	$0.74	Release
Q2 FY2024ended Mar 31, 2024	May 9, 2024before the open	$287.20M	+3.6%	$0.50	$0.67	Release
Q1 FY2024ended Dec 31, 2023	Feb 9, 2024before the open	$277.30M	+0.6%	$0.35	$0.61	Release
Q4 FY2023ended Sep 30, 2023	Nov 21, 2023before the open	$281.90M	+2.7%	$0.10	$0.59	Release
Q3 FY2023ended Jun 30, 2023	Aug 8, 2023before the open	$286.10M	-1.7%	$0.26	$0.69	Release
Q2 FY2023ended Mar 31, 2023	May 12, 2023before the open	$277.10M	+0.9%	$0.24	$0.75	Release
Q1 FY2023ended Dec 31, 2022	Feb 14, 2023before the open	$275.70M	–	$0.61	$0.96	Release
Q4 FY2022ended Sep 30, 2022	Dec 20, 2022before the open	$274.60M	–	-$0.30	–	Release
Q3 FY2022ended Jun 30, 2022	Aug 15, 2022before the open	$291.10M	–	$1.07	–	Release
Q2 FY2022ended Mar 31, 2022	May 13, 2022before the open	$274.50M	–	$1.38	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Embecta's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Adjusted Organic Constant Currency Revenue Growth (%)non-GAAP	FY2026	-10.2% – -8.3%	-2% – 0%	Lowered	May 5, 2026
Reported Revenue Growth (%)	FY2026	-6.1% – -4.2%	–	New	May 5, 2026
Reported Revenue Growth (%)GAAP	FY2026	-0.9% – +1.1%	–	New	Feb 5, 2026
Reported Revenues	FY2026	$1.02B – $1.04B	–	New	May 5, 2026
Reported RevenuesGAAP	FY2026	$1.07B – $1.09B	$1.07B – $1.09B	Reaffirmed	Feb 5, 2026
Adjusted Operating Margin (%)non-GAAP	FY2026	22.25% – 23.25%	29% – 30%	Lowered	May 5, 2026
Adjusted Earnings per Diluted Sharenon-GAAP	FY2026	$1.55 – $1.75	$2.80 – $3.00	Lowered	May 5, 2026
Impact of F/X (%)	FY2026	1.5%	1.2%	Raised	May 5, 2026
Impact of Italian Payback Measure (2) (%)	FY2026	-0.1%	-0.1%	Lowered	May 5, 2026
M&A (3) (%)	FY2026	2.7%	–	Raised	May 5, 2026
repay debt	FY2026	$150.00M	–	New	May 5, 2026

Guidance vs results

The last range Embecta gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Adjusted Earnings per Diluted Share	$2.90 – $2.95	$2.97Σ4Q	Above range
FY2025	Revenue	$1.08B – $1.09B	$1.08BΣ4Q	Within range
FY2025	Revenue growth	-4% – -3.4%	-3.8%Σ4Q	Within range

Guidance history

Every forecast Embecta put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
May 5, 2026	Adjusted Earnings per Diluted Share	FY2026	$1.55 – $1.75	Lowered
May 5, 2026	dilutive to adjusted earnings per share	FY2026	$0.15	Lowered
May 5, 2026	Adjusted Operating Margin (%)	FY2026	22.25% – 23.25%	Lowered
May 5, 2026	Impact of F/X (%)	FY2026	1.5%	Raised
May 5, 2026	Impact of Italian Payback Measure (2) (%)	FY2026	-0.1%	Lowered
May 5, 2026	M&A (3) (%)	FY2026	2.7%	Raised
May 5, 2026	repay debt	FY2026	$150.00M	New
May 5, 2026	Reported Revenue Growth (%)	FY2026	-6.1% – -4.2%	New
May 5, 2026	Adjusted Organic Constant Currency Revenue Growth (%)	FY2026	-10.2% – -8.3%	Lowered
May 5, 2026	Reported Revenues	FY2026	$1.02B – $1.04B	New
May 5, 2026	revenue	FY2026	$30.00M	Lowered
Feb 5, 2026	Adjusted Earnings per Diluted Share	FY2026	$2.80 – $3.00	Reaffirmed
Feb 5, 2026	Adjusted Operating Margin (%)	FY2026	29% – 30%	Reaffirmed
Feb 5, 2026	Impact of F/X (%)	FY2026	1.2%	New
Feb 5, 2026	Impact of Italian Payback Measure (2) (%)	FY2026	-0.1%	Lowered
Feb 5, 2026	Reported Revenue Growth (%)	FY2026	-0.9% – +1.1%	New
Feb 5, 2026	Adjusted Constant Currency Revenue Growth (%)	FY2026	-2% – 0%	Reaffirmed
Feb 5, 2026	Reported Revenues	FY2026	$1.07B – $1.09B	Reaffirmed
Nov 25, 2025	Adjusted Earnings per Diluted Share	FY2026	$2.80 – $3.00	New
Nov 25, 2025	Adjusted Operating Margin (%)	FY2026	29% – 30%	New
Nov 25, 2025	Adjusted Constant Currency Revenue Growth (%)	FY2026	-2% – 0%	New
Nov 25, 2025	Reported Revenues	FY2026	$1.07B – $1.09B	New
Aug 8, 2025	Adjusted EBITDA Margin (%)	FY2025	37.25% – 37.5%	New
Aug 8, 2025	Adjusted Earnings per Diluted Share	FY2025	$2.90 – $2.95	New
Aug 8, 2025	Adjusted Gross Margin (%)	FY2025	63.25% – 63.5%	New
Aug 8, 2025	Adjusted Operating Margin (%)	FY2025	30.75% – 31%	New
Aug 8, 2025	Reported Revenue Growth (%)	FY2025	-4% – -3.4%	New
Aug 8, 2025	Adjusted Constant Currency Revenue Growth (%)	FY2025	-3.6% – -3%	New
Aug 8, 2025	Reported Revenues	FY2025	$1.08B – $1.09B	New
May 9, 2025	Adjusted EBITDA Margin (%)	FY2025	36.25% – 37.25%	Raised
May 9, 2025	Adjusted Earnings per Diluted Share	FY2025	$2.70 – $2.90	Reaffirmed
May 9, 2025	Adjusted Gross Margin (%)	FY2025	62.75% – 63.75%	Lowered
May 9, 2025	Adjusted Operating Margin (%)	FY2025	29.75% – 30.75%	Raised
May 9, 2025	Impact of F/X (%)	FY2025	-0.8%	Lowered
May 9, 2025	Impact of Italian Payback Measure (2) (%)	FY2025	0.4%	Raised
May 9, 2025	Reported Revenue Growth (%)	FY2025	-4.4% – -2.9%	New
May 9, 2025	Adjusted Constant Currency Revenue Growth (%)	FY2025	-4% – -2.5%	Lowered
May 9, 2025	Reported Revenues	FY2025	$1.07B – $1.09B	New
Feb 6, 2025	Adjusted Earnings per Diluted Share	FY2025	$2.70 – $2.90	Reaffirmed
Feb 6, 2025	Adjusted Gross Margin (%)	FY2025	63.25% – 64.25%	Reaffirmed
Feb 6, 2025	Adjusted Operating Margin (%)	FY2025	29.5% – 30.5%	Raised
Feb 6, 2025	Impact of F/X (%)	FY2025	-2.2%	Lowered
Feb 6, 2025	Impact of Italian Payback Measure (2) (%)	FY2025	0.4%	Raised
Feb 6, 2025	Adjusted EBITDA Margin (%)	FY2025	36% – 37%	New
Feb 6, 2025	Reported Revenue Growth (%)	FY2025	-4.3% – -2.8%	Lowered
Feb 6, 2025	Adjusted Constant Currency Revenue Growth (%)	FY2025	-2.5% – -1%	Reaffirmed
Feb 6, 2025	Reported Revenues	FY2025	$1.08B – $1.09B	Lowered
Nov 26, 2024	Adjusted EBITDA Margin (%)	FY2025	35.5% – 36.5%	New
Nov 26, 2024	Adjusted Earnings per Diluted Share	FY2025	$2.70 – $2.90	New
Nov 26, 2024	Adjusted Gross Margin (%)	FY2025	63.25% – 64.25%	New
Nov 26, 2024	Adjusted Operating Margin (%)	FY2025	29% – 30%	New
Nov 26, 2024	Impact of F/X (%)	FY2025	-0.6%	New
Nov 26, 2024	Impact of Italian Payback Measure (1) (%)	FY2025	0.4%	Raised
Nov 26, 2024	Reported Revenue Growth (%)	FY2025	-2.7% – -1.2%	New
Nov 26, 2024	Adjusted Constant Currency Revenue Growth (%)	FY2025	-2.5% – -1%	New
Nov 26, 2024	Reported Revenues	FY2025	$1.09B – $1.11B	New
Aug 9, 2024	Adjusted EBITDA Margin (%)	FY2024	31.25% – 31.5%	Raised
Aug 9, 2024	Adjusted Earnings per Diluted Share	FY2024	$2.30 – $2.35	Raised
Aug 9, 2024	Adjusted Gross Margin (%)	FY2024	65.25% – 65.5%	Raised
Aug 9, 2024	Adjusted Operating Margin (%)	FY2024	25.75% – 26%	Raised
Aug 9, 2024	Constant Currency (%)	FY2024	-0.5% – 0%	Reaffirmed
Aug 9, 2024	Revenues	FY2024	$1.11B – $1.12B	Reaffirmed
May 9, 2024	Adjusted EBITDA Margin (%)	FY2024	31% – 31.5%	Raised
May 9, 2024	Adjusted Earnings per Diluted Share	FY2024	$2.20 – $2.30	Raised
May 9, 2024	Adjusted Gross Margin (%)	FY2024	64.5% – 65%	Raised
May 9, 2024	Adjusted Operating Margin (%)	FY2024	25.25% – 25.75%	Raised
May 9, 2024	Constant Currency (%)	FY2024	-0.5% – 0%	Raised
May 9, 2024	Revenues	FY2024	$1.11B – $1.12B	Raised
Feb 9, 2024	Adjusted EBITDA Margin (%)	FY2024	29.5% – 30.5%	Reaffirmed
Feb 9, 2024	Adjusted Earnings per Diluted Share	FY2024	$1.95 – $2.15	Raised
Feb 9, 2024	Adjusted Gross Margin (%)	FY2024	63% – 64%	Reaffirmed
Feb 9, 2024	Adjusted Operating Margin (%)	FY2024	23.75% – 24.75%	Reaffirmed
Feb 9, 2024	Constant Currency (%)	FY2024	-2% – 0%	Reaffirmed
Feb 9, 2024	Revenues	FY2024	$1.09B – $1.12B	Raised
Nov 21, 2023	Adjusted EBITDA Margin (%)	FY2024	29.5% – 30.5%	New
Nov 21, 2023	Adjusted Earnings per Diluted Share	FY2024	$1.90 – $2.10	New
Nov 21, 2023	Adjusted Gross Margin (%)	FY2024	63% – 64%	New
Nov 21, 2023	Adjusted Operating Margin (%)	FY2024	23.75% – 24.75%	New
Nov 21, 2023	Constant Currency (%)	FY2024	-2% – 0%	New
Nov 21, 2023	Revenues	FY2024	$1.09B – $1.11B	New
Aug 8, 2023	Adjusted EBITDA Margin (%)	FY2023	33.5%	Raised
Aug 8, 2023	Adjusted Earnings per Diluted Share	FY2023	$2.75 – $2.80	Raised
Aug 8, 2023	Adjusted Gross Margin (%)	FY2023	66%	Raised
Aug 8, 2023	Adjusted Operating Margin (%)	FY2023	29.5%	Raised
Aug 8, 2023	Contract Manufacturing	FY2023	$11.00M	New
Aug 8, 2023	Constant Currency (%)	FY2023	+0.5% – +1%	Raised
Aug 8, 2023	Revenues	FY2023	$1.11B – $1.11B	Raised
May 12, 2023	Adjusted EBITDA Margin (%)	FY2023	32.5%	Raised
May 12, 2023	Adjusted Earnings per Diluted Share	FY2023	$2.50 – $2.60	Raised
May 12, 2023	Adjusted Gross Margin (%)	FY2023	64.5%	Raised
May 12, 2023	Adjusted Operating Margin (%)	FY2023	28%	Raised
May 12, 2023	Constant Currency (%)	FY2023	0% – +1%	Raised
May 12, 2023	Revenues	FY2023	$1.10B – $1.11B	Raised
Feb 14, 2023	Adjusted EBITDA Margin (%)	FY2023	31.5%	Raised
Feb 14, 2023	Adjusted Diluted Earnings per Share	FY2023	$2.20 – $2.35	Raised
Feb 14, 2023	Adjusted Gross Margin (%)	FY2023	63.5%	Raised
Feb 14, 2023	Adjusted Operating Margin (%)	FY2023	26.5%	Raised
Feb 14, 2023	Constant Currency (%)	FY2023	-1.5% – +0.5%	Raised
Feb 14, 2023	Revenues	FY2023	$1.08B – $1.11B	Raised
Dec 20, 2022	Adjusted EBITDA Margin (%)	FY2023	30%	New
Dec 20, 2022	Adjusted Diluted Earnings per Share	FY2023	$1.75 – $2.00	New
Dec 20, 2022	Adjusted Gross Margin (%)	FY2023	62%	New
Dec 20, 2022	Adjusted Operating Margin (%)	FY2023	25%	New
Dec 20, 2022	Constant Currency (%)	FY2023	-2% – 0%	New
Dec 20, 2022	Revenues	FY2023	$1.05B – $1.07B	New
Aug 15, 2022	Constant Currency (%)	FY2022	-3%	New
Aug 15, 2022	Revenues	FY2022	$555.00M	Reaffirmed
May 13, 2022	Expense associated with transition services agreement activities	FY2022	$35.00M	New
May 13, 2022	Total revenue	FY2022	$555.00M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.